Co-Diagnostics says new FDA policy to help expand use of COVID-19 test
Co-Diagnostics Inc said on
Tuesday the U.S. Food and Drug Administration’s new policy to
expand availability of COVID-19 tests will allow the medical
test maker’s tests to be distributed to a wide array of U.S.
labs.
Tuesday the U.S. Food and Drug Administration’s new policy to
expand availability of COVID-19 tests will allow the medical
test maker’s tests to be distributed to a wide array of U.S.
labs.
Posted by Reuters
